Ignite Creation Date:
2024-05-06 @ 1:08 AM
Last Modification Date:
2024-10-26 @ 10:59 AM
Study NCT ID:
NCT01735305
Status:
COMPLETED
Last Update Posted:
2015-12-11
First Post:
2012-11-12
Brief Title:
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
Sponsor:
Shenyang Northern Hospital
Organization:
Shenyang Northern Hospital
Study Overview
Official Title:
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
Status:
COMPLETED
Status Verified Date:
2015-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPT-CAD
Brief Summary:
Antiplatelet therapy is the cornerstone for the prevention of atherothrombosis in patients with coronary artery disease CAD However the efficacy and safety of antiplatelet therapy are varied due to ethnic andor individual variability The aim of the OPT-CAD study was to demonstrate contemporary status and outcomes of antiplatelet therapy in Chinese CAD patients and to explore predictors of ischemic or bleeding events in such cohortPatients above 18 years old who were diagnosed as CAD and received antiplatelet therapy were prospectively enrolled in this national wide non-intervention registry All medications and laboratory tests were physician discretion
Detailed Description:
Antiplatelet therapy is the cornerstone for the prevention of atherothrombosis in patients with coronary artery disease CAD However the efficacy and safety of antiplatelet therapy are varied due to ethnic andor individual variability The aim of the OPT-CAD study was to demonstrate contemporary status and outcomes of antiplatelet therapy in Chinese CAD patients and to explore predictors of ischemic or bleeding events in such cohortPatients above 18 years who were diagnosed as CAD and received antiplatelet therapy were prospectively enrolled in this national wide non-intervention registry All medications and laboratory tests were at physician discretion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None